Background The clinical efficacy and safety of maintenance therapy (MT) for patients with
advanced non-small cell lung cancer (NSCLC) have not been determined in the real word …

Background: The purpose of this study was to explore the role of maintenance therapy for
patients with advanced non-small cell lung cancer (NSCLC) in a real-world setting. Patients …

Objectives Although maintenance therapy has been a routine treatment paradigm for
advanced non-small cell lung cancer (NSCLC), there is currently lack of direct evidence to …

Several randomized trials have recently investigated the role of maintenance treatment for
patients with advanced non-small-cell lung cancer (NSCLC) with responding or stable …

Introduction Non–small cell lung cancer (NSCLC) is often diagnosed at later stages when
treatment options are limited. Maintenance therapy may prolong the time to disease …

Purpose The aim was to investigate whether maintenance therapy (MT) is sufficient or not to
improve overall survival (OS) and progress-free survival (PFS) of advanced non-small cell …

Opinion statement The standard of care for the treatment of patients with advanced NSCLC
includes 4-6 cycles of platinum-doublet chemotherapy with or without bevacizumab, with …

BACKGROUND: Maintenance therapy is a new treatment paradigm for advanced non-small
cell lung cancer (NSCLC). We conducted a meta-analysis of randomized studies with single …

With standard doublet chemotherapy for patients with advanced non-small-cell lung cancer
(NSCLC), we have reached an outcome plateau of about 10 months median overall survival …

Background Maintenance therapy for patients with non-small cell lung cancer (NSCLC) has
gained extensive interest. Varying results for this treatment underpin the need for a synthesis …